Cell Transformation, Neoplastic - 25 Studies Found Active, not recruiting : Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer : Adult Solid Neoplasm Hormone-Resistant Prostate Cancer Rec : 2011-11-23 : Drug: Akt Inhibitor MK2206 Giv Completed : Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation : Leukemia : 2007-10-22 : Biological: GM-CSF Dosing sche Active, not recruiting : A Phase II Study to Evaluate the Efficacy and the Safety of Flumatinib in CML-AP or CML-BP Patients : Chronic Myelogenous Leukemia : 2015-07-26 : Drug: Flumatinib mesylate tablet 600 mg qd Flumatinib mesylate tablet 600 mg qd in CML-AP or CML-BP pati Active, not recruiting : Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML : Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leuk : 2013-05-06 : Drug: metformin hydrochloride Recruiting : Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML : Chronic Myeloid Leukemia in Myeloid Blast Crisis Untreated Adult Acute Myeloid Leukemia : 2012-09-11 : Drug: Nilotinib+AD induction • Post-remission consol Recruiting : An Open-Label, Phase I/II Study of Two Different Schedules of Dasatinib (Sprycel) and Decitabine (Dacogen) Used in Combination for Patients With Accelerated or Blastic Phase Chronic Myelogenous Leukemia (Protocol CA180357) : Leukemia : 2011-12-21 : Drug: Dasatinib Starting Dose: Completed : Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 Trial : Chronic Myelogenous Leukemia : 2011-06-06 : Drug: nilotinib Other Name: AMN107 Terminated : Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia : Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Drug: entinostat Given orally Completed : A Study of Nilotinib in Adult Patients With Imatinib Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase : Chronic Myeloid Leukemia : 2010-05-18 : Drug: Nilotinib Approved for marketing : Nilotinib in Adult Patients With Imatinib-resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase : Chronic Myeloid Leukemia : 2009-05-18 : Drug: Nilotinib <<< Previous | Next >>>